Chemomab Therapeutics Ltd DRC (CMMB) — Cash Flow Quality Index

Latest as of December 2019: -0.69x

Chemomab Therapeutics Ltd DRC (CMMB) has a Cash Flow Quality Index of -0.69x as of December 2019. Operating cash flow of $-6.26 Million is below net income of $9.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chemomab Therapeutics Ltd DRC (CMMB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.69x

Operating CF / Net Income

Operating Cash Flow

$-6.26 Million

USD

Net Income

$9.08 Million

USD

Data as of

Dec 2019

Most recent filing

Annual Cash Flow Quality Index for Chemomab Therapeutics Ltd DRC (None–None)

Year-by-year earnings quality comparison for Chemomab Therapeutics Ltd DRC.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.